Latest Articles
PD-1 Inhibitors Improve Survival for dMMR Endometrial Cancer - Medscape Reference
PD-1 Inhibitors Improve Survival for dMMR Endometrial Cancer Medscape Reference
Published: June 17, 2026, 2:51 p.m.
Identification of BAY-439 - A Selective Human Phospholipase A2 Group V Inhibitor - Evotec
Identification of BAY-439 - A Selective Human Phospholipase A2 Group V Inhibitor Evotec
Published: June 5, 2026, 1:36 p.m.
Optimizing Biomarker-Driven Treatment and Immune Checkpoint Inhibitor Counseling in Endometrial Cancer - Pharmacy Times
Optimizing Biomarker-Driven Treatment and Immune Checkpoint Inhibitor Counseling in Endometrial Cancer Pharmacy Times
Published: May 28, 2026, 8:50 p.m.
Biomarker Testing and Immune Checkpoint Inhibitor Counseling Shape Endometrial Cancer Care - Pharmacy Times
Biomarker Testing and Immune Checkpoint Inhibitor Counseling Shape Endometrial Cancer Care Pharmacy Times
Published: May 27, 2026, 4:12 p.m.
Immune Checkpoint Inhibitors Transform Frontline Endometrial Cancer Care - Pharmacy Times
Immune Checkpoint Inhibitors Transform Frontline Endometrial Cancer Care Pharmacy Times
Published: May 26, 2026, 3:57 p.m.
TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight - The Malaysian Reserve
TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight The Malaysian Reserve
Published: Feb. 2, 2026, 11:43 p.m.
Aprea Therapeutics Announces Early Clinical Proof-Of-Concept in the Ongoing ACESOT-1051 Dose-Escalation Trial Evaluating WEE1 Inhibitor APR-1051, Including Partial Response Observed on First Scan - The Manila Times
Aprea Therapeutics Announces Early Clinical Proof-Of-Concept in the Ongoing ACESOT-1051 Dose-Escalation Trial Evaluating WEE1 Inhibitor APR-1051, Including Partial Response Observed on First Scan The Manila Times
Published: Jan. 29, 2026, 1:43 p.m.
Popular 4p hot drink could aid weight loss by mimicking GLP-1 inhibitors - chroniclelive.co.uk
Popular 4p hot drink could aid weight loss by mimicking GLP-1 inhibitors chroniclelive.co.uk
Published: Jan. 22, 2026, 3:03 p.m.
Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer - Targeted Oncology
Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer Targeted Oncology
Published: Jan. 11, 2026, 4:14 p.m.
WRN Inhibitors Market Enters Growth Phase with Multiple Early-Stage Clinical Programs Underway | DelveInsight - The Malaysian Reserve
WRN Inhibitors Market Enters Growth Phase with Multiple Early-Stage Clinical Programs Underway | DelveInsight The Malaysian Reserve
Published: Nov. 12, 2025, 11:52 p.m.
Link copied to clipboard!